Delphine Launay

Design, synthesis and biological evaluation of 2-substituted quinolines as potential antileishmanial agents

Vadiraj S. Gopinath, Jakir Pinjari, Ravindra T. Dere et al. · European Journal of Medicinal Chemistry · 2013 · 76 citations

Pharmacy, Medicinal Chemistry, Pharmacology +14

Nitroimidazo-oxazole compound DNDI-VL-2098: an orally effective preclinical drug candidate for the treatment of visceral leishmaniasis

Suman Gupta, Vanessa Yardley, Preeti Vishwakarma et al. · Journal of Antimicrobial Chemotherapy · 2014 · 66 citations

Veterinary Medicine, Infectious Diseases, Pharmacology +17

7-Substituted 2-Nitro-5,6-dihydroimidazo[2,1-<i>b</i>][1,3]oxazines: Novel Antitubercular Agents Lead to a New Preclinical Candidate for Visceral Leishmaniasis

Andrew M. Thompson, P. D. T. O’Connor, Andrew J. Marshall et al. · Journal of Medicinal Chemistry · 2017 · 58 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +13

Repositioning Antitubercular 6-Nitro-2,3-dihydroimidazo[2,1-<i>b</i>][1,3]oxazoles for Neglected Tropical Diseases: Structure–Activity Studies on a Preclinical Candidate for Visceral Leishmaniasis

Andrew M. Thompson, P. D. T. O’Connor, Adrian Blaser et al. · Journal of Medicinal Chemistry · 2016 · 57 citations

Pharmacy, Medicinal Chemistry, Pharmacology +13

Aminothiazoles: Hit to lead development to identify antileishmanial agents

Debnath Bhuniya, Rao Mukkavilli, Rahul Shivahare et al. · European Journal of Medicinal Chemistry · 2015 · 39 citations

Pharmacy, Medicinal Chemistry, Pharmacology +12